Agenus (AGEN) Operating Margin Growth (3y) (2013 - 2026)

Agenus (AGEN) Operating Margin Growth (3y) (2013 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin Growth (3y) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 9,942.00
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 530.00
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -1,211.00
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -623.00
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Agenus 184.05 Mn 177.29 Mn 33.74 Mn 28,190.00

Historic Data

Download Data
DateValue
Mar 31, 2026 28,190.00
Dec 31, 2025 -8,817.00
Sep 30, 2025 16,785.00
Jun 30, 2025 14,792.00
Mar 31, 2025 8,139.00
Dec 31, 2024 17,016.00
Sep 30, 2024 -19,959.00
Jun 30, 2024 49,035.00
Mar 31, 2024 23,561.00
Dec 31, 2023 6,442.00
Sep 30, 2023 4,396.00
Jun 30, 2023 -9,262.00
Mar 31, 2023 -5,573.00
Dec 31, 2022 18,613.00
Sep 30, 2022 -272.00
Jun 30, 2022 4,886.00
Mar 31, 2022 -16,950.00
Dec 31, 2021 34,449.00
Sep 30, 2021 27,782.00
Jun 30, 2021 -51,452.00